Serum Predose Metabolic Profiling for Prediction of Rosuvastatin Pharmacokinetic Parameters in Healthy Volunteers
Rosuvastatin is a well-known lipid-lowering agent generally used for hypercholesterolemia treatment and coronary artery disease prevention. There is a substantial inter-individual variability in the absorption of statins usually caused by genetic polymorphisms leading to a variation in the correspon...
Enregistré dans:
Auteurs principaux: | Anne Michelli Reis Silveira, Gustavo Henrique Bueno Duarte, Anna Maria Alves de Piloto Fernandes, Pedro Henrique Dias Garcia, Nelson Rogerio Vieira, Marcia Aparecida Antonio, Patricia de Oliveira Carvalho |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ee722c3b6d8b41b6b7a2d30a17918c5e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
par: ASHFAQ,MUHAMMAD, et autres
Publié: (2013) -
ROSUVASTATIN AS A POSSIBLE TREATMENT FOR SUDDEN SENSORINEURAL HEARING LOSS
par: Nadeem Ul Haq, et autres
Publié: (2019) -
Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
par: Parson H
Publié: (2010) -
Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage
par: Zi L, et autres
Publié: (2021) -
Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin
par: Wang Z, et autres
Publié: (2013)